(Date:11/6/2009)...r 6 EUCODIS Bioscience, a company,...ing enzymes for the,chemical industry announced to...with Bio Sidus, the leading biopharmaceutical comp...es EUCODIS Bioscience exclusive access - for the s...ietary collection of,psychrophilic bacteria strain...
(Date:11/6/2009)...6 Calbiotech, Inc. announced today...ive Research (SBIR) Phase I contract by the U.S. A...erms of the agreement, Calbiotech will develop ana... Dengue virus. ,, Dengue virus is a mosquito... military forces deployed to tropical areas of the...
(Date:11/6/2009)...ewswire/ -- Intarcia Therapeutics, Inc. delivered ...4; continuous delivery of exenatide) program for t...l Diabetes Technology Meeting in San Francisco, CA...h/20050301/SFTU126LOGO ) ,, Continuous Subcut...lasma Glucose, HbA1c and Reduces Weight in a 28-da...
(Date:11/5/2009)... . . . , Fuel economy ratings for the new 2010....fueleconomy.gov web site, which Oak Ridge Nation... Department of Energy and the U.S. Environmental P...he best fuel economy list are hybrid electrics, le...This list proves that hybrids have gone mainstream...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3...by EBS is without merit and part of its overall st...iness without getting shareholder, approval and t...nding to PSC., -...o pursue its business, strategy of obtaining FDA a... and seeking additional federal and third party...
...evenues increased 38% to $42.3 million Full...n, SHANGHAI, China, July 10 /Xinhua-PRNewswire-Fi...d: CHBT) ("China-Biotics", "the,Company"), a leadi...search, development, marketing and distribution of... results for the fourth quarter and fiscal,year en...
...nce, July 10 , - 1st Half-Year Sales Up 16%, - ...reater than or equal,to)12%, EUR millions .../07 EURM %Sales EURM %S... change chang... 13 26.8 71 15 Other EU countries (2) ...
Other Biology Technology:Protein Sciences Responds to Emergent BioSolutions Lawsuit 2Protein Sciences Responds to Emergent BioSolutions Lawsuit 3Protein Sciences Responds to Emergent BioSolutions Lawsuit 4Protein Sciences Responds to Emergent BioSolutions Lawsuit 5China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 2China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 3China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 4China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 5China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 6China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 7China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 8China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 9China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 10China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 11China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 12China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results 13Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth 2...mal model for the painful nerve condition known as...at it, according to Duke University bioengineers a... but rather a diverse range of symptoms, such as n...adiating leg pain or difficulty in controlling the...ng, of any of the five nerve roots that combine to...
...at Scripps Institution of Oceanography at UC San D...tures below the cobalt blue waters of Lake Tahoe o...ripps research team offer a more comprehensive ana...ion, which suggest a magnitude-7 earthquake occurs... the largest fault in the basin, West Tahoe, appea...
...en using a growing volume of genetic data to debat...to the New World in one wave or successive waves, ... of different populations. , Now, after painstaki...f modern-day Native American and Eurasian groups, ...put the matter to rest: Virtually without exceptio...
Other Biology News:Limping rat provides sciatica insights 2Scripps studies offer new picture of Lake Tahoe's earthquake potential 2Native Americans descended from a single ancestral group, DNA study confirms 2Native Americans descended from a single ancestral group, DNA study confirms 3... V is a fully integrated system for fluorescent b...that deliver excellent quality microarray images. ...er that is based on patented confocal laser imagin...spatial resolution. The DNAscope V images two fluo...
Rabbit Anti-Ca2+ Channel Ca gamma 2 Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Rabbit Anti-Nuclear Receptor Coactivator 2 (NCOA2) Polyclonal Antibody, Agarose Conjugated from Novus Biologicals
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: